DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option
Department of Defense
Description
The Peer Reviewed Cancer Research Program (PRCRP) Clinical Development Award for fiscal year 2025 supports early-career cancer researchers, known as Principal Investigators (PIs), in advancing their research and career development. It has two options: the Fellow Option for those within seven years post-terminal degree, excluding certain times, and the Resident Option for clinicians in residency aiming to become physician-scientists. Applicants must focus on a critical cancer-related issue an…
Summary: The fiscal year 2025 (FY25) Peer Reviewed Cancer Research Program (PRCRP) Clinical Development Award - Fellow and Resident Option (CDA-FRO) supports the advancement of cancer research through development of early-career investigators. Under this award mechanism, the ear…
Source
Grant ID
HT942525PRCRPCDAFRO
Agency
Department of Defense
Subcategory/Subagency
Dept. of the Army -- USAMRAA
Eligibility
The following categories of applicants are invited to apply:
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Awards & Funding
Total Funding
$6.7M
Funding Amount
Discretionary
Links
Documents
Similar opportunities
- DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
Department of Defense
- Forecast to Publish a Notice of Funding Opportunity for Paul Calabresi Career Development Award in Clinical Oncology (K12 Clinical Trial Optional)
Department of Health and Human Services
- Notice to Publish a Funding Opportunity Announcement for the Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Not Allowed)
Department of Health and Human Services
- Research Specialist Award (R50) in Cancer Research
National Institutes of Health
- Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS)
Department of Health and Human Services